It is time for Congress to make it crystal clear that contract pharmacies are integral to the 340B program, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell’s blog.
Federal courts have struck down federal agency letters to six drug makers telling them their 340B contract pharmacy policies are illegal, Slafsky points out. That means the government probably will be unable to enforce the 340B contract pharmacy program for months or years, he said. More drug companies probably will announce restrictions, he predicted.
Slafsky said he is pleased that some provider groups have come out in favor of a legislative solution to the contract pharmacy impasse. But with the November elections getting closer, time to pass a bill is running out, he warned.
“340B providers need to begin a full-court press today,” Slafsky said.
You can read Slafsky’s article here.